MedPath

Interest and Impact of Skin Cancer Genetic Testing

Completed
Conditions
Non-melanoma Skin Cancer (NMSC)
Interventions
Genetic: MC1R genotyping
Behavioral: MC1R Testing Website
Behavioral: Baseline Survey
Registration Number
NCT02941900
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
53
Inclusion Criteria
  • 18 years of age or older
  • English fluent as we do not have the resources to translate all the materials including the website and risk feedback materials into other languages
  • Prior history of stage 0, I or II NMSC as per EMR or clinical judgment
Read More
Exclusion Criteria
  • Inability to provide meaningful informed consent due to cognitive or psychiatric disability as determined by the judgement of the consenting professional or clinician
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Non-melanoma skin cancers (NMSCs)MC1R genotyping-
Non-melanoma skin cancers (NMSCs)Baseline Survey-
Non-melanoma skin cancers (NMSCs)MC1R Testing Website-
Primary Outcome Measures
NameTimeMethod
number of patients interested in MC1R testing1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath